Five things to know about Trump’s FDA lead pick Gottlieb March 24, 2017 By Karen Appold On March 10, the White House announced that President Donald Trump selected Scott Gottlieb, MD, who has worked for FDA in the past, as his choice to head the FDA. Here are five things managed healthcare executives should know about the pick. Opinion: More industry-stakeholders play blame game for high drug costs March 23, 2017 By Devon Herrick PhD Our policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs. Independent Pharmacy Cooperative and Pace Alliance Join Together February 22, 2017 By Nicholas Hamm IPC and Pace Alliance join together to help the independent pharmacist. New diabetes medications help address linked diseases Experts share updates on new diabetes medications, and provide an overview of what’s coming. Watch list 2017: Top therapeutic areas January 03, 2017 By Mari Edlin Find out about the latest treatment and drug pipeline developments Top pharmacy challenges of 2017 December 28, 2016 By Mari Edlin High drug prices continue to plague payers, but various contributing factors intensify the problem. Will new autoimmune drugs address cost concerns? December 27, 2016 By Erin Bastick PharmD Find out what’s in the drug pipeline for autoimmune disease. Top 2017 challenges healthcare executives face December 08, 2016 By Karen Appold Results from Managed Healthcare Executive’s annual State of the Industry Survey reveal which issues will hit managed healthcare hardest in 2017. Four innovative models rein in pharma costs December 05, 2016 By Mari Edlin Plans and PBMs are finding new ways to rein in pharmacy costs. Online drug pricing tools that influence consumers October 26, 2016 By Mari Edlin Consumers are demanding transparency in the prices of drugs. Here’s how they are getting it.